Announcement on Wholly-owned Subsidiary Obtaining Notice of Approval for Drug Clinical Trials

About this update from Vcanbio Cell & Gene Engineering Corp., Ltd. Class A

Announcement on Wholly-owned Subsidiary Obtaining Notice of Approval for Drug Clinical TrialsThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Vcanbio Cell & Gene Engineering Corp., Ltd. Class A